Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited Announces Equity Awards
JERSEY, Channel Islands , Nov. 19, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Ali Kiboro, who has been appointed as the Chief Financial Officer of the Company effective
View HTML
Toggle Summary Quotient Limited Provides Second Quarter Fiscal 2022 Results
Alba by Quotient: Revenues exceeded guidance; Achieved year-over year growth in Q2 FY 2022 of 15.9% Financial Position: Available cash & short-term investments of $141.8 million Business Update: Communication issued on November 9, 2021 ; providing a progress update on development and upcoming
View HTML
Toggle Summary Quotient Limited to Participate in the Jefferies London Healthcare Conference
JERSEY, Channel Islands , Nov. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 8:40am GMT ( 3:40am ET ).
View HTML
Toggle Summary Quotient Limited Provides Business Update and Delays Releasing Second Quarter Fiscal 2022 Results
Executive Leadership Team: Recent new hires will support anticipated rapid growth and help lead future development MosaiQ™ Solution Transfusion Dx: The Expanded Immunohematology CE regulatory dossier has been submitted with 20 specificities; and Expanded Serological Disease Screening immunoassay
View HTML
Toggle Summary Quotient Limited to Report Second Quarter Fiscal Year 2022 Financial Results and Host Conference Call
JERSEY, Channel Islands , Oct. 26, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that financial results for its fiscal second quarter ended September 30, 2021 will be released before market open on Tuesday, November 9,
View HTML
Toggle Summary Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Principal Payments on 12% Senior Secured Notes
Notes holders unanimously consent to amendments Company’s near-term cash obligations reduced by approximately $60 million Transaction extends liquidity runway through commercial launch and provides resources for further MosaiQ investment JERSEY, Channel Islands , Oct.
View HTML
Toggle Summary Quotient Limited Announces Appointment of Chief Financial Officer
JERSEY, Channel Islands , Oct. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company’s Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1 st , 2021, replacing Mr.
View HTML
Toggle Summary Quotient Limited Announces Appointment of Chief Commercial Officer
JERSEY, Channel Islands , Oct. 05, 2021 (GLOBE NEWSWIRE) --   Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Mohammad El Khoury as the Company’s Chief Commercial Officer. In this role, Mr. El Khoury will oversee all commercial activities for the company as
View HTML
Toggle Summary Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
JERSEY, Channel Islands , Oct. 04, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Scientific & Medical Officer (CSMO). “We are delighted to welcome Dr.
View HTML
Toggle Summary Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray
JERSEY, Channel Islands , Oct. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the launch of the review process of the Expanded Immunohematology (IH) technical file dossier for review by the European notified body.
View HTML